Finance

Lists
Q3 2026 earnings • released • EPS beat +14,014.11% • Revenue met 0.00%
See results
PHM:BME
Pharma Mar SA
€65.85
-2.44%
(-1.65) 1D
Nov 2, 5:36:00 PM GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for PHM...
Open
€67.25
High
€67.40
Low
€65.20
Mkt. cap
1.22B
Avg. vol.
27.85K
Volume
57.28K
Dividend
1.52%
Quarterly dividend
€0.25
Ex-dividend date
Jun 7, 2023
P/E ratio
20.04
52-wk high
€105.20
52-wk low
€64.00
EPS
€3.29
Shares outstanding
18.00M
No. of employees
505
Open
€67.25
High
€67.40
Low
€65.20
Mkt. cap
1.22B
Avg. vol.
27.85K
Volume
57.28K
Dividend
1.52%
Quarterly dividend
€0.25
Ex-dividend date
Jun 7, 2023
P/E ratio
20.04
52-wk high
€105.20
52-wk low
€64.00
EPS
€3.29
Shares outstanding
18.00M
No. of employees
505
News stories
From web sources and news partners
About Pharma Mar SA
CEO-
Employees505
Founded1986
Headquarters-
SectorBiotechnology
Last report
Oct 29, 2026
Fiscal period
Q3 2026
€0.47 / €0.00
+14,014.11%beat
Revenue / Est. (EUR)
0.00 / 50.68M
0.00%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
90.48M
42.90M
49.60M
54.42M
Cost of goods sold
3.77M
3.66M
4.73M
3.67M
Cost of revenue
3.77M
3.66M
4.73M
3.67M
Research and development expenses
25.59M
20.88M
26.38M
24.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.31M
15.31M
17.12M
15.53M
Operating expense
43.09M
38.62M
46.28M
43.10M
Total operating expenses
46.87M
42.28M
51.01M
46.77M
Operating income
43.61M
622.00K
-1.40M
7.65M
Other non operating income
-
-
-
-
EBT including unusual items
44.28M
1.60M
-993.00K
8.14M
EBT excluding unusual items
44.28M
1.60M
-993.00K
8.14M
Income tax expense
-15.39M
65.00K
-21.00K
-1.00K
Effective tax rate
-34.75%
4.07%
2.11%
-0.01%
Other operating expenses
195.00K
2.43M
2.77M
2.71M
Net income
59.66M
1.53M
-972.00K
8.14M
Net profit margin
65.95%
3.57%
-1.96%
14.96%
Earnings per share
-
-
-
-
Interest and investment income
3.44M
976.00K
412.00K
492.00K
Interest expense
-724.00K
-
-
-
Net interest expenses
2.72M
976.00K
412.00K
492.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
45.64M
2.71M
700.00K
9.78M
Gain or loss from assets sale
-754.00K
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps